AI Science Tracker
EN

AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer.

Affiliation not stated in the reviewed material · 31 Mar 2026 · medicine

Discovery

AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary source Methods/Results confirm the represented result: Retrospective single-centre study where AI-powered CT sarcopenia (skeletal muscle index) software predicts neoadjuvant chemotherapy response in muscle-invasive bladder cancer; a clinically specific retrospective assessment. The result is reported in the La radiologia medica. Affiliation was not stated in the reviewed material. It does not establish generalization beyond the reported setting or prospective real-world benefit.

Technology: Retrospective single-centre study where AI-powered CT sarcopenia (skeletal muscle index) software predicts neoadjuvant chemotherapy response in muscle-invasive bladder cancer

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Retrospective single-centre study where AI-powered CT sarcopenia (skeletal muscle index) software predicts neoadjuvant chemotherapy response in muscle-invasive bladder cancer
Test and result
The primary source Methods/Results confirm the represented result: Retrospective single-centre study where AI-powered CT sarcopenia (skeletal muscle index) software predicts neoadjuvant chemotherapy response in muscle-invasive bladder cancer; a clinically specific retrospective assessment.
Limitation / still unknown
Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1007/s11547-026-02203-2

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.